- World Pharma News Home » Published News » Product
(a free service delivered by FeedBurner)
The U.S. Food and Drug Administration approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
AstraZeneca and Abbott announced today that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR® (rosuvastatin calcium), a medication used along with diet to reduce high
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Pfizer Inc announced that, in patients with heart disease, type 2 diabetes and chronic kidney disease, Lipitor® (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular eve
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of Actemra (tocilizumab), a novel interleukin
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the State Food and Drug Administration (SFDA) of China has approved Nexavar® (sorafenib) tablets for the treatment
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Finalising a review of the safety of moxifloxacin-containing medicines for oral use, the European Medicines Agency (EMEA) has concluded that these medicines should only be prescribed in the treatment
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of Medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial sh
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Pfizer announced that new statin users who took Lipitor® (atorvastatin calcium) were significantly more likely to stay on their medication compared to those who took simvastatin, according to an obse
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of Cervarix®, its vaccine to prevent cervical cancer.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline's (GSK) cervical cancer vaccine, Cervarix TM, was confirmed as the UK Department of Health's vaccine of choice for its national human papillomavirus (HPV) immunisation programme. Th
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
